Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss.

Julia Anthony from SOLUtion Medical emphasizes usability and patient-centric design for the company’s dual chamber prefilled ...

The global epinephrine auto-injector market is set for steady expansion, driven by the increasing prevalence of severe allergies worldwide. According to market projections, global sales of epinephrine ...

You can install Opentelemetry Operator via Helm Chart from the opentelemetry-helm-charts repository. More information is available in here. WARNING: Until the ...

CNBC Select evaluated dozens of auto loan lenders based on their rates and terms, selection of loan options, car-buying experience and other factors. Below are our picks for the best auto loan ...

Canada Objective To determine whether the use of glucagon-like peptide-1 (GLP-1) receptor agonists is associated with an increased risk of suicidal ideation, self-harm, and suicide among patients with ...

Samantha is a freelance contributor to Newsweek’s personal finance team. With a passion for finance, real estate and travel, Samantha has written hundreds of articles to help others use money as ...

New pricing aims to attract cash-paying customers via LillyDirect Hims & Hers warns it may stop selling compounded version of Novo Nordisk weight-loss drugs Telehealth firms' shares fall The move ...

Google has just started the rollout of a new Android Auto update, and the good news is that this version seems to resolve a major glitch hitting wireless users. Before delving into details ...

2019 The FDA accepts for review Xeris Pharmaceuticals ' (XERS -0.3%) marketing application seeking approval for a ready-to-use, room temperature-stable liquid glucagon auto-injector ...